Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors.
Saved in:
| Title: | Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors. |
|---|---|
| Authors: | Muraro E; Immunopathology and Cancer Biomarkers, Department of Translational Research, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Montico B; Immunopathology and Cancer Biomarkers, Department of Translational Research, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Lum B; Frazer Institute, The University of Queensland, Brisbane, QLD, Australia., Colizzi F; Immunopathology and Cancer Biomarkers, Department of Translational Research, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Giurato G; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Baronissi, Italy.; Genome Research Center for Health - CRGS, Baronissi, Italy., Salvati A; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Baronissi, Italy.; Genome Research Center for Health - CRGS, Baronissi, Italy.; Molecular Pathology and Medical Genomics Program, AOU 'S. Giovanni di Dio e Ruggi d'Aragona' University of Salerno and Rete Oncologica Campana, Salerno, Italy., Guerrieri R; Immunopathology and Cancer Biomarkers, Department of Translational Research, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Rizzo A; Immunopathology and Cancer Biomarkers, Department of Translational Research, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Comaro E; Immunopathology and Cancer Biomarkers, Department of Translational Research, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Canzonieri V; Division of Pathology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy., Anichini A; Human Tumors Immunobiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Del Vecchio M; Melanoma Unit, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Mortarini R; Human Tumors Immunobiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Milione M; Pathology Unit 1, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Weisz A; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Baronissi, Italy.; Genome Research Center for Health - CRGS, Baronissi, Italy.; Molecular Pathology and Medical Genomics Program, AOU 'S. Giovanni di Dio e Ruggi d'Aragona' University of Salerno and Rete Oncologica Campana, Salerno, Italy., Pizzichetta MA; Division of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.; Department of Dermatology, University of Trieste, Trieste, Italy., Simpson F; Frazer Institute, The University of Queensland, Brisbane, QLD, Australia., Dolcetti R; Translational and Clinical Immunotherapy, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Department of Microbiology and Immunology, The University of Melbourne, Melbourne, VIC, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia., Fratta E; Immunopathology and Cancer Biomarkers, Department of Translational Research, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Sigalotti L; Oncogenetics and Functional Oncogenomics Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy. |
| Source: | Frontiers in immunology [Front Immunol] 2024 Mar 06; Vol. 15, pp. 1336566. Date of Electronic Publication: 2024 Mar 06 (Print Publication: 2024). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38510242 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Muraro+E%22">Muraro E</searchLink>; Immunopathology and Cancer Biomarkers, Department of Translational Research, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.<br /><searchLink fieldCode="AU" term="%22Montico+B%22">Montico B</searchLink>; Immunopathology and Cancer Biomarkers, Department of Translational Research, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.<br /><searchLink fieldCode="AU" term="%22Lum+B%22">Lum B</searchLink>; Frazer Institute, The University of Queensland, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Colizzi+F%22">Colizzi F</searchLink>; Immunopathology and Cancer Biomarkers, Department of Translational Research, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.<br /><searchLink fieldCode="AU" term="%22Giurato+G%22">Giurato G</searchLink>; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Baronissi, Italy.; Genome Research Center for Health - CRGS, Baronissi, Italy.<br /><searchLink fieldCode="AU" term="%22Salvati+A%22">Salvati A</searchLink>; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Baronissi, Italy.; Genome Research Center for Health - CRGS, Baronissi, Italy.; Molecular Pathology and Medical Genomics Program, AOU 'S. Giovanni di Dio e Ruggi d'Aragona' University of Salerno and Rete Oncologica Campana, Salerno, Italy.<br /><searchLink fieldCode="AU" term="%22Guerrieri+R%22">Guerrieri R</searchLink>; Immunopathology and Cancer Biomarkers, Department of Translational Research, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.<br /><searchLink fieldCode="AU" term="%22Rizzo+A%22">Rizzo A</searchLink>; Immunopathology and Cancer Biomarkers, Department of Translational Research, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.<br /><searchLink fieldCode="AU" term="%22Comaro+E%22">Comaro E</searchLink>; Immunopathology and Cancer Biomarkers, Department of Translational Research, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.<br /><searchLink fieldCode="AU" term="%22Canzonieri+V%22">Canzonieri V</searchLink>; Division of Pathology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.<br /><searchLink fieldCode="AU" term="%22Anichini+A%22">Anichini A</searchLink>; Human Tumors Immunobiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Del+Vecchio+M%22">Del Vecchio M</searchLink>; Melanoma Unit, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Mortarini+R%22">Mortarini R</searchLink>; Human Tumors Immunobiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Milione+M%22">Milione M</searchLink>; Pathology Unit 1, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Weisz+A%22">Weisz A</searchLink>; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Baronissi, Italy.; Genome Research Center for Health - CRGS, Baronissi, Italy.; Molecular Pathology and Medical Genomics Program, AOU 'S. Giovanni di Dio e Ruggi d'Aragona' University of Salerno and Rete Oncologica Campana, Salerno, Italy.<br /><searchLink fieldCode="AU" term="%22Pizzichetta+MA%22">Pizzichetta MA</searchLink>; Division of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.; Department of Dermatology, University of Trieste, Trieste, Italy.<br /><searchLink fieldCode="AU" term="%22Simpson+F%22">Simpson F</searchLink>; Frazer Institute, The University of Queensland, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Dolcetti+R%22">Dolcetti R</searchLink>; Translational and Clinical Immunotherapy, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Department of Microbiology and Immunology, The University of Melbourne, Melbourne, VIC, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Fratta+E%22">Fratta E</searchLink>; Immunopathology and Cancer Biomarkers, Department of Translational Research, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.<br /><searchLink fieldCode="AU" term="%22Sigalotti+L%22">Sigalotti L</searchLink>; Oncogenetics and Functional Oncogenomics Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Mar 06; Vol. 15, pp. 1336566. <i>Date of Electronic Publication: </i>2024 Mar 06 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38510242 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2024.1336566 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1336566 Titles: – TitleFull: Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Muraro E – PersonEntity: Name: NameFull: Montico B – PersonEntity: Name: NameFull: Lum B – PersonEntity: Name: NameFull: Colizzi F – PersonEntity: Name: NameFull: Giurato G – PersonEntity: Name: NameFull: Salvati A – PersonEntity: Name: NameFull: Guerrieri R – PersonEntity: Name: NameFull: Rizzo A – PersonEntity: Name: NameFull: Comaro E – PersonEntity: Name: NameFull: Canzonieri V – PersonEntity: Name: NameFull: Anichini A – PersonEntity: Name: NameFull: Del Vecchio M – PersonEntity: Name: NameFull: Mortarini R – PersonEntity: Name: NameFull: Milione M – PersonEntity: Name: NameFull: Weisz A – PersonEntity: Name: NameFull: Pizzichetta MA – PersonEntity: Name: NameFull: Simpson F – PersonEntity: Name: NameFull: Dolcetti R – PersonEntity: Name: NameFull: Fratta E – PersonEntity: Name: NameFull: Sigalotti L IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 03 Text: 2024 Mar 06 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
